...
首页> 外文期刊>Current opinion in anaesthesiology >Fluid management in the cardiothoracic intensive care unit: Diuresis-diuretics and hemofiltration
【24h】

Fluid management in the cardiothoracic intensive care unit: Diuresis-diuretics and hemofiltration

机译:心胸重症监护病房的液体管理:利尿-利尿剂和血液滤过

获取原文
获取原文并翻译 | 示例
           

摘要

PURPOSE OF REVIEW: The present review discusses the current concepts of fluid management in cardiothoracic surgery, and its clinical implications with special reference to organ-related complications and their prevention. RECENT FINDINGS: Current strategies in fluid management for cardiothoracic patients, various fluid formulation, and the preventive strategies for minimizing fluid-related complications are described, with particular reference to new discoveries and controversies that have arisen from recent literature. SUMMARY: The optimal fluid management in cardiothoracic patients has not been settled. Results of recent clinical published trials highlight the need for minimizing fluid administration and attempting to use diuretics to achieve a negative fluid, although hypovolemia and hypoperfusion should be carefully considered. An individualized optimization of fluid status, using goal-directed therapy, has emerged as a possible preferable approach. The old debate between crystalloid and colloid solutions has been partially solved, as some colloids have demonstrated deleterious effect on renal function and coagulation system. Various preventive strategies have also emerged for minimizing fluid-related complications.
机译:综述的目的:本综述讨论心胸外科手术中液体管理的当前概念及其临床意义,并特别提及器官相关并发症及其预防。最近的发现:描述了心胸患者液体管理的当前策略,各种液体配方以及将与液体有关的并发症减少到最低程度的预防策略,特别是参考了最近文献中出现的新发现和争议。摘要:心胸患者的最佳体液管理尚未解决。尽管应仔细考虑血容量不足和血流灌注不足,但最近发表的临床试验结果表明,有必要尽量减少输液量并尝试使用利尿剂使体液呈阴性。使用目标导向疗法对体液状态进行个性化优化已成为一种可能的首选方法。晶体和胶体溶液之间的古老争论已部分解决,因为一些胶体已显示出对肾功能和凝血系统的有害作用。还出现了各种预防策略以最小化与液体有关的并发症。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号